CAIHL read · Jun 11, 2026
'A leader in health AI': School of Medicine Dean talks integration of artificial intelligence and healthcare
Framework
What CAIHL does
Critical AI Health Literacy (CAIHL) is an analytical lens — Hugo Campos and Liz Salmi's 2025 National Academy of Medicine commentary, "Critical AI Health Literacy as Liberation Technology." It applies Paulo Freire's theory of critical literacy to health AI.
The central question CAIHL asks is whose interests does this AI actually serve? Four dimensions answer it: who is the primary user, where is it hosted, whose interests does it advance, and does it expand or constrain patient agency.
This deep-read separates the four dimensions on a single item from the day's scan, so you can see the specific structural shape of the AI in question — not just the bucket it landed in.
The four dimensions
How this item reads through CAIHL
Primary user
patient
Patients, families, and care partners are the primary users of this AI.
Hosting
institutional
Hosted inside a health system, insurer, or large employer. Access controlled by the institution.
Interests
institutional
Prioritizes institutional efficiency, compliance, risk management, or revenue.
Agency
neutral
Neither clearly expanding nor constraining patient agency.
Editor's CAIHL read
One-sentence synthesis
Academic-medical-center AI-branding framing; agency direction depends entirely on whether the disclosure floor catches up.
In the scan
How this item appeared in the daily scan
Editor's note: Academic medical centers competing on 'leader in health AI' branding is the layer most invisible to the patient inside the AMC. The branding precedes the disclosure floor by a multi-year lag.
Summary: Duke Chronicle: Profile-and-interview piece on the Duke School of Medicine Dean on the institution's positioning as a 'leader in health AI' — the institutional-branding layer underneath which the clinical deployment is being planned.
methodology
Limitations
CAIHL is a lens, not a verdict. The four dimensions are conditions of use — reassess them when a tool's business model, deployment context, or patient behavior changes. See the NAM commentary for the full framework.